TY - JOUR
T1 - Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains
AU - Lingel, Amy
AU - Lin, Haishuang
AU - Gavriel, Yuval
AU - Weaver, Eric
AU - Polepole, Pascal
AU - Lopez, Virginia
AU - Lei, Yuguo
AU - Petro, Thomas M.
AU - Solomon, Beka
AU - Zhang, Chi
AU - Zhang, Luwen
N1 - Publisher Copyright:
© 2020 American Society for Biochemistry and Molecular Biology Inc.. All rights reserved.
PY - 2020/12/11
Y1 - 2020/12/11
N2 - Zika virus (ZIKV) is a neurotropic flavivirus that causes several diseases including birth defects such as microcephaly. Intrinsic immunity is known to be a frontline defense against viruses through host anti-viral restriction factors. Limited knowledge is available on intrinsic immunity against ZIKV in brains. Amyloid precursor protein (APP) is predominantly expressed in brains and implicated in the pathogenesis of Alzheimer's diseases. We have found that ZIKV interacts with APP, and viral infection increases APP expression via enhancing protein stability. Moreover, we identified the viral peptide, HGSQHSGMIVNDTGHETDENRAKVEITPNSPRAEATLGGFGSLGL, which is capable of enhancing APP expression. We observed that aging brain tissues with APP had protective effects on ZIKV infection by reducing the availability of the viruses. Also, knockdown of APP expression or blocking ZIKV-APP interactions enhanced ZIKV replication in human neural progenitor/stem cells. Finally, intracranial infection of ZIKV in APP-null neonatalmice resulted in highermortality and viral yields. Taken together, these findings suggest that APP is a restriction factor that protects against ZIKV by serving as a decoy receptor, and plays a protective role in ZIKV-mediated brain injuries.
AB - Zika virus (ZIKV) is a neurotropic flavivirus that causes several diseases including birth defects such as microcephaly. Intrinsic immunity is known to be a frontline defense against viruses through host anti-viral restriction factors. Limited knowledge is available on intrinsic immunity against ZIKV in brains. Amyloid precursor protein (APP) is predominantly expressed in brains and implicated in the pathogenesis of Alzheimer's diseases. We have found that ZIKV interacts with APP, and viral infection increases APP expression via enhancing protein stability. Moreover, we identified the viral peptide, HGSQHSGMIVNDTGHETDENRAKVEITPNSPRAEATLGGFGSLGL, which is capable of enhancing APP expression. We observed that aging brain tissues with APP had protective effects on ZIKV infection by reducing the availability of the viruses. Also, knockdown of APP expression or blocking ZIKV-APP interactions enhanced ZIKV replication in human neural progenitor/stem cells. Finally, intracranial infection of ZIKV in APP-null neonatalmice resulted in highermortality and viral yields. Taken together, these findings suggest that APP is a restriction factor that protects against ZIKV by serving as a decoy receptor, and plays a protective role in ZIKV-mediated brain injuries.
UR - http://www.scopus.com/inward/record.url?scp=85097585155&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097585155&partnerID=8YFLogxK
U2 - 10.1074/jbc.RA120.015165
DO - 10.1074/jbc.RA120.015165
M3 - Article
C2 - 33028637
AN - SCOPUS:85097585155
SN - 0021-9258
VL - 295
SP - 17114
EP - 17127
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 50
ER -